SANOFI US SERVICES INC. for SANOFI US SERVICES INC
What was lobbied
5 issue areas, each in the filer's own words, with who lobbied on it and where.
Pharmacy PHA
Issues related to the TRICARE retail rebate program.
| Lobbyist | Covered position, as disclosed |
|---|---|
| RICHARD M HODGE | — |
| PATRICK MAYES MCLAIN | — |
Taxation/Internal Revenue Code TAX
Extension of the R&D tax credit including Section 111 of H.R. 4213, Tax Extenders Act of 2009; and all such provisions in HR 422 "To amend the Internal Revenue Code of 1986 to extend the research credit through 2010 and to increase and make permanent the alternative simplified research credit" and S1203 "Grow Research Opportunities with Tax Credits' Help Act" or "GROWTH Act" ; international tax treaties and the ratification of the Second Protocol to the Income Tax Treaty between the U.S. and France.
Foreign entity interest: sanofi-aventis SA
| Lobbyist | Covered position, as disclosed |
|---|---|
| EDWARD GREISSING | — |
| PATRICK MAYES MCLAIN | — |
| ANN TAYLOR | — |
Copyright/Patent/Trademark CPT
All provisions of S369 "Protecting Access to Affordable Generic Drugs Act of 2009"; all provisions of S515 and HR1260 "The Patent Reform Act of 2009"
| Lobbyist | Covered position, as disclosed |
|---|---|
| EDDIE D EVANS | — |
| EDWARD GREISSING | — |
| PATRICK MAYES MCLAIN | — |
Health Issues HCR
Provisions and issues related to patient access to and the coverage, payment and pricing of pharmaceuticals, provisions related to intellectual property and issues related to a regulatory pathway and reimbursement for follow-on biologics, issues related to cancer awareness and access to treatment, issues and provisions related to the 340B federal Safety Net Drug Pricing Program, issues and provisions related to comparative effectiveness, and issues and provisions related to the Independent Medicare Advisory Committee in HR3590"The Patient Protection and Affordable Care Act." All provisions of SAmdt2952 to HR3590. General issues related to the Medicare Part D program including patient access to pharmaceuticals, issues related to awareness of atrial fibrillation and access to treatment, issues related to cancer awareness and access to treatment; and H Res 231 "Supporting the goals and ideals of 'Deep Vein Thrombosis Awareness Month' and 'National DVT Screening Day' and supporting efforts to educate the public about deep vein thrombosis, in memory of former Representative Jennifer Dunn."
| Lobbyist | Covered position, as disclosed |
|---|---|
| TIMOTHY CLARK | — |
| MARK COIN | — |
| EDDIE D EVANS | — |
| EDWARD GREISSING | — |
| RICHARD M HODGE | — |
| PATRICK MAYES MCLAIN | — |
| SAIRA SULTAN | — |
| ANN TAYLOR | — |
Medicare/Medicaid MMM
General issues related to the Medicare Part D program including patient access to pharmaceuticals; issues related to ASP reporting of marketed products and reimbursement under Medicare Part B; and issues related to VTE quality measures under the Medicare Part A reporting measures for hospital aquired conditions
| Lobbyist | Covered position, as disclosed |
|---|---|
| MARK COIN | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.